Goldman Sachs reiterates Buy for Haleon stock at GBp 460.00

Published on 10/27/2026 at 12:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Goldman Sachs kept a GBp 460.00 target on October 23, 2026. Haleon stock costs EUR 4.57 on October 27, 2026 versus EUR 4.56 Xetra close.

Analyst view and upcoming update

Goldman Sachs maintained a GBp 460.00 target on October 23, 2026.
Haleon's investment case includes 4-6 percent annual organic revenue growth.
Haleon stock trades at EUR 4.57 at 12:50 p.m. CET at Lang & Schwarz on October 27, 2026, 0.15 percent above the Xetra close of October 26, 2026.
Haleon's Q3 2026 trading statement is scheduled for October 29, 2026.

Haleon, GB00BMX86B70, Illustration mit AI erstellt.

Haleon (ISIN GB00BMX86B70) stock trades at EUR 4.57 at Lang & Schwarz on October 27, 2026, 0.15 percent above the EUR 4.56 Xetra close of October 26, 2026. Markets Insider reported that Goldman Sachs reiterated its Buy rating and GBp 460.00 price target on October 23, 2026.

Three recent Haleon signals

Haleon's recent sequence points to a stock approaching a scheduled operating update. On October 12, 2026, MarketScreener reported that UBS expected Haleon to tighten its fiscal 2026 organic sales growth guidance to 3.10 percent. On October 16, 2026, Deep Malde joined Haleon as Head of Expert Marketing and Transformation after more than eight years in marketing leadership roles, according to Pitch. Goldman Sachs then reiterated the GBp 460.00 target on October 23, 2026.

What sets the next test?

The operating framework gives investors two measurable reference points. Haleon's investor-relations page describes annual organic revenue growth of 4-6 percent and high-single-digit adjusted operating profit growth at constant currency. It also highlights GBP 800 million in gross cost savings planned over five years, making execution and volume trends central to the next update, according to Haleon.

Next reporting date

Haleon lists October 29, 2026, for its Q3 2026 trading statement and webcast. The date provides the next formal checkpoint for sales growth, guidance and the savings program.

Stock holds near EUR 4.57

Haleon operates in consumer healthcare, with brands spanning oral health, pain relief, respiratory products, vitamins and digestive health. Its London listing uses ticker HLN, while the German euro indication gives investors a separate intraday reference before the company update.

Haleon stock was trading at EUR 4.57 at Lang & Schwarz on October 27, 2026 at 12:50 p.m. CET, up 0.15 percent versus the Xetra close of October 26, 2026 at EUR 4.56. The further course of trading is shown by the continuously updated real-time quote of Haleon stock.